NLVP

New Leaf Venture Partners Portfolio holdings

AUM $52.9M
This Quarter Return
+35.41%
1 Year Return
-33.65%
3 Year Return
+15.24%
5 Year Return
+39.89%
10 Year Return
+615.06%
AUM
$206M
AUM Growth
Cap. Flow
+$206M
Cap. Flow %
100%
Top 10 Hldgs %
97.88%
Holding
13
New
13
Increased
Reduced
Closed
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ARAV
1
DELISTED
Aravive, Inc. Common Stock
ARAV
$51.6M 25.09% +2,296,471 New +$51.6M
RLYP
2
DELISTED
RELYPSA INC COM
RLYP
$50.5M 24.57% +1,639,665 New +$50.5M
CMRX
3
DELISTED
Chimerix, Inc.
CMRX
$43M 20.93% +1,068,300 New +$43M
OXFD
4
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$18.8M 9.13% +1,377,497 New +$18.8M
CALA
5
DELISTED
Calithera Biosciences, Inc
CALA
$12.6M 6.14% +624,786 New +$12.6M
MEIP icon
6
MEI Pharma
MEIP
$160M
$6.84M 3.33% +1,601,390 New +$6.84M
ALDR
7
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$6.5M 3.16% +223,553 New +$6.5M
KPTI icon
8
Karyopharm Therapeutics
KPTI
$61.7M
$4.74M 2.31% +126,687 New +$4.74M
MRNS
9
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$4.43M 2.16% +419,388 New +$4.43M
ACAD icon
10
Acadia Pharmaceuticals
ACAD
$4.38B
$2.18M 1.06% +68,761 New +$2.18M
DVAX icon
11
Dynavax Technologies
DVAX
$1.19B
$1.9M 0.92% +112,700 New +$1.9M
SAGE
12
DELISTED
Sage Therapeutics
SAGE
$1.3M 0.63% +35,370 New +$1.3M
ALIM
13
DELISTED
Alimera Sciences, Inc.
ALIM
$1.16M 0.57% +209,691 New +$1.16M